OBJECTIVE: To compare the global effects of oxidized LDL (oxLDL) and oxLDL-containing immune complexes (oxLDL-IC) on gene expression in human monocytic cells and to identify differentially expressed genes involved with inflammation and survival. METHODS AND RESULTS: U937 cells were treated with oxLDL-IC, oxLDL, Keyhole limpet hemocyanin immune complexes (KLH-IC), or vehicle for 4h. Transcriptome profiling was performed using DNA microarrays. oxLDL-IC uniquely affected the expression of genes involved with pro-survival (RAD54B, RUFY3, SNRPB2, and ZBTB24). oxLDL-IC also regulated many genes in a manner similar to KLH-IC. Functional categorization of these genes revealed that 39% are involved with stress responses, including the unfolded protein response which impacts cell survival, 19% with regulation of transcription, 10% with endocytosis and intracellular transport of protein and lipid, and 16% with inflammatory responses including regulation of I-kappaB /NF-kappaB cascade and cytokine activity. One gene in particular, HSPA6, greatly up-regulated by oxLDL-IC, was found to be required for the process by which oxLDL-IC augments IL1-beta secretion. The study also revealed genes uniquely up-regulated by oxLDL, including genes involved with growth inhibition (OKL38, NEK3, and FTH1), oxidoreductase activity (SPXN1 and HMOX1), and transport of amino acids and fatty acids (SLC7A11 and ADFP). CONCLUSIONS: These findings highlight early transcriptional responses elicited by oxLDL-IC that may underlie its cytoprotective and pro-inflammatory effects. Cross-linking of Fc gamma receptors appears to be the trigger for most of the transcriptional responses to oxLDL-IC. The findings further strengthen the hypothesis that oxLDL and oxLDL-IC elicit disparate inflammatory responses and play distinct roles in the process of atherosclerosis.
OBJECTIVE: To compare the global effects of oxidized LDL (oxLDL) and oxLDL-containing immune complexes (oxLDL-IC) on gene expression in human monocytic cells and to identify differentially expressed genes involved with inflammation and survival. METHODS AND RESULTS: U937 cells were treated with oxLDL-IC, oxLDL, Keyhole limpet hemocyanin immune complexes (KLH-IC), or vehicle for 4h. Transcriptome profiling was performed using DNA microarrays. oxLDL-IC uniquely affected the expression of genes involved with pro-survival (RAD54B, RUFY3, SNRPB2, and ZBTB24). oxLDL-IC also regulated many genes in a manner similar to KLH-IC. Functional categorization of these genes revealed that 39% are involved with stress responses, including the unfolded protein response which impacts cell survival, 19% with regulation of transcription, 10% with endocytosis and intracellular transport of protein and lipid, and 16% with inflammatory responses including regulation of I-kappaB /NF-kappaB cascade and cytokine activity. One gene in particular, HSPA6, greatly up-regulated by oxLDL-IC, was found to be required for the process by which oxLDL-IC augments IL1-beta secretion. The study also revealed genes uniquely up-regulated by oxLDL, including genes involved with growth inhibition (OKL38, NEK3, and FTH1), oxidoreductase activity (SPXN1 and HMOX1), and transport of amino acids and fatty acids (SLC7A11 and ADFP). CONCLUSIONS: These findings highlight early transcriptional responses elicited by oxLDL-IC that may underlie its cytoprotective and pro-inflammatory effects. Cross-linking of Fc gamma receptors appears to be the trigger for most of the transcriptional responses to oxLDL-IC. The findings further strengthen the hypothesis that oxLDL and oxLDL-IC elicit disparate inflammatory responses and play distinct roles in the process of atherosclerosis.
Authors: M F Lopes-Virella; S Koskinen; M Mironova; D Horne; R Klein; C Chassereau; C Enockson; G Virella Journal: Atherosclerosis Date: 2000-09 Impact factor: 5.162
Authors: Vidya V Kunjathoor; Maria Febbraio; Eugene A Podrez; Kathryn J Moore; Lorna Andersson; Stephanie Koehn; Jeongmi S Rhee; Roy Silverstein; Henry F Hoff; Mason W Freeman Journal: J Biol Chem Date: 2002-10-09 Impact factor: 5.157
Authors: A J Oliveira-Dos-Santos; G Matsumoto; B E Snow; D Bai; F P Houston; I Q Whishaw; S Mariathasan; T Sasaki; A Wakeham; P S Ohashi; J C Roder; C A Barnes; D P Siderovski; J M Penninger Journal: Proc Natl Acad Sci U S A Date: 2000-10-24 Impact factor: 11.205
Authors: P X Shaw; S Hörkkö; S Tsimikas; M K Chang; W Palinski; G J Silverman; P P Chen; J L Witztum Journal: Arterioscler Thromb Vasc Biol Date: 2001-08 Impact factor: 8.311
Authors: Kent J Smith; Waleed O Twal; Farzan Soodavar; Gabriel Virella; Maria F Lopes-Virella; Samar M Hammad Journal: J Biol Chem Date: 2010-03-26 Impact factor: 5.157
Authors: Ronald Klein; Chelsea E Myers; Kristine E Lee; Andrew D Paterson; Karen J Cruickshanks; Michael Y Tsai; Ronald E Gangnon; Barbara E K Klein Journal: JAMA Ophthalmol Date: 2015-09 Impact factor: 7.389
Authors: Jean-Philip Truman; Mohammed M Al Gadban; Kent J Smith; Russell W Jenkins; Nalini Mayroo; Gabriel Virella; Maria F Lopes-Virella; Alicja Bielawska; Yusuf A Hannun; Samar M Hammad Journal: Immunology Date: 2012-05 Impact factor: 7.397
Authors: Mohammed M Al Gadban; Kent J Smith; Farzan Soodavar; Christabelle Piansay; Charlyne Chassereau; Waleed O Twal; Richard L Klein; Gabriel Virella; Maria F Lopes-Virella; Samar M Hammad Journal: PLoS One Date: 2010-09-02 Impact factor: 3.240
Authors: Maria F Lopes-Virella; Kelly J Hunt; Nathaniel L Baker; Gabriel Virella; Thomas Moritz Journal: Atherosclerosis Date: 2012-08-21 Impact factor: 5.162